Sinovac Biotech Receives RMB 100 Million Loan To Produce H1N1 Vaccine

Sinovac Biotech, the only member in the influenza vaccine supply international task force from China, has signed the country's first influenza A (H1N1) vaccine production contract with the Beijing Centers for Disease Control and Prevention. From August, 5 million doses of the vaccine will be supplied to the city in three batches. To support Sinovac's production, the Bank of Beijing has provided the firm a loan of over RMB 100 million ($14.6 million), which exceeds the total loans Sinovac received from the bank in the past six years. (Click here for more - Chinese Language)